Status:
COMPLETED
Elucidating the Role of Microvascular Dysfunction in Heart Disease in Women
Lead Sponsor:
Oregon Health and Science University
Conditions:
Microvascular Dysfunction
Eligibility:
FEMALE
45-75 years
Brief Summary
The purpose of this study is to determine if women with chest pain and "clean" heart blood vessels have impaired blood flow to the heart due to problems with the small blood vessels that provide blood...
Eligibility Criteria
Inclusion
- Women 45 to 75 years of age
Exclusion
- Pregnancy
- Allergy to any component of the drugs: Definity®. Dipyridamole Aminophyllin or Iodine.
- Known coronary heart disease, significant valvular disease (valvular stenosis or insufficiency greater than moderate) left ventricular systolic dysfunction, congenital heart disease or cardiac shunt, pulmonary hypertension, moderate or severe asthma.
- Inability to reach the patient by mail, fax, e-mail or phone
- Active infection
- Malignancy
- Uncontrolled hypertension
- Smoking
- Severe asthma
- Kidney disease
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00663520
Start Date
January 1 2008
End Date
February 1 2014
Last Update
April 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health and Science University
Portland, Oregon, United States, 97239